海外の治験の状況「前立腺癌」での検索結果
109件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- Metastatic Castration-Resistant Prostate Cancer
- Australia, Canada, France, Germany, New Zealand, Spain, United Kingdom, United States
- 2016-08-03
Recruiting
- Evaluating the Impact of Androgen Deprivation Therapy on Cognition in an Australian Sample of Prostate Cancer Patients
- Prostate Cancer;Cognitive function
- Australia
- 2016-07-29
Recruiting
- A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
- Cancer of the Prostate;Metastatic Cancer
- Australia
- 2017-12-11
Recruiting
- Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);HRD
- Australia, Puerto Rico
- 2018-10-11
Recruiting
- A single arm, prospective Phase II study of Split-Course Pelvic Radiotherapy for Locally Progressive, Castrate Resistant Prostate Cancer
- Castrate Resistant Prostate Cancer
- Australia
- 2014-08-11
Recruiting
- A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer # Prostate Cancer # Cancer of the Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Province of China, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-06-23
Recruiting
- A Multicentre External Beam Radiotherapy Study Using Stereotactic Boost for Prostate Cancer Patients
- Prostate Cancer; br>Prostate Cancer;Cancer - Prostate
- Australia
- 2015-03-09
Recruiting
- Phase II Trial of Pembrolizumab (MK-3475) in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Chemotherapy (KEYNOTE-199)
- Metastatic Castration-resistant Prostate Cancer (mCRPC);C61 - Malignant neoplasm of prostate
- Australia, Canada, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Spain, Sweden, Switzerland, Taiwan, Province of China, Turkey, United Kingdom, United States
- 2016-10-17
Recruiting
- Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer
- Cancer
- Australia, New Zealand
- 2017-09-27
Recruiting
- Health Technology Assessment of the Clarity Autoscan system: Motion correction and margin reduction in the radiation therapy treatment of prostate cancer
- prostate cancer
- Australia
- 2017-07-28